{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:44:16Z","timestamp":1791042256859,"version":"4.1.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.2215\/cjn.01720211","type":"journal-article","created":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T00:46:26Z","timestamp":1312505186000},"page":"2374-2383","source":"Crossref","is-referenced-by-count":124,"title":["Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease"],"prefix":"10.2215","volume":"6","author":[{"given":"Eva","family":"Schepers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela V.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griet","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Eloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fellype C.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20230601","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R2-9-20230601","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/eurheartj\/ehl455","article-title":"The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years","volume":"28","author":"Van Biesen","year":"2007","journal-title":"Eur Heart J"},{"key":"R3-9-20230601","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","article-title":"Chronic kidney disease as cause of cardiovascular morbidity and mortality","volume":"20","author":"Vanholder","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R4-9-20230601","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-9-20230601","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"R6-9-20230601","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","article-title":"Asymmetrical dimethylarginine: The Uber marker?","volume":"109","author":"Cooke","year":"2004","journal-title":"Circulation"},{"key":"R7-9-20230601","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00228-005-0010-1","article-title":"Effects of asymmetric dimethylarginine (ADMA) infusion in humans","volume":"62","author":"Kielstein","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"R8-9-20230601","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","article-title":"Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study)","volume":"53","author":"Meinitzer","year":"2007","journal-title":"Clin Chem"},{"key":"R9-9-20230601","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"R10-9-20230601","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2008.10.040","article-title":"Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population","volume":"205","author":"Kiechl","year":"2009","journal-title":"Atherosclerosis"},{"key":"R11-9-20230601","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2010.150854","article-title":"Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: The Ludwigshafen Risk and Cardiovascular Health Study","volume":"57","author":"Meinitzer","year":"2011","journal-title":"Clin Chem"},{"key":"R12-9-20230601","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.atherosclerosis.2009.06.039","article-title":"Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke","volume":"208","author":"Schulze","year":"2010","journal-title":"Atherosclerosis"},{"key":"R13-9-20230601","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/ATVBAHA.108.162768","article-title":"Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction","volume":"28","author":"Zeller","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R14-9-20230601","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/ndt\/gfn670","article-title":"Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes","volume":"24","author":"Schepers","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R15-9-20230601","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","article-title":"Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease","volume":"17","author":"Bode-B\u00f6ger","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R16-9-20230601","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B","volume":"1","author":"Closs","year":"1997","journal-title":"Nitric Oxide"},{"key":"R17-9-20230601","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: Classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"key":"R18-9-20230601","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1523-1755.2004.00631.x","article-title":"In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection","volume":"65","author":"Glorieux","year":"2004","journal-title":"Kidney Int"},{"key":"R19-9-20230601","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(96)00073-7","article-title":"The use of human monocytoid lines as indicators of endotoxin","volume":"194","author":"Eperon","year":"1996","journal-title":"J Immunol Methods"},{"key":"R20-9-20230601","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0006-2952(02)01292-3","article-title":"Potentiation of 1,25-dihydroxyvitamin D(3)-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone","volume":"64","author":"Kim","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"R21-9-20230601","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0145-2126(97)00156-2","article-title":"Induction of the differentiation of HL-60 promyelocytic leukemia cells by nonsteroidal anti-inflammatory agents in combination with low levels of vitamin D3","volume":"22","author":"Sokoloski","year":"1998","journal-title":"Leuk Res"},{"key":"R22-9-20230601","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1097-0320(19971001)29:2<182::AID-CYTO12>3.0.CO;2-S","article-title":"Novel flow cytometric method for quantifying nuclear binding of the transcription factor nuclear factor kappa B in unseparated human monocytes and polymorphonuclear cells","volume":"29","author":"Foulds","year":"1997","journal-title":"Cytometry"},{"key":"R23-9-20230601","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2009.503","article-title":"Plasma IL-6 is independently associated with mortality in both hemodialysis and pre-dialysis CKD patients","volume":"77","author":"Barreto","year":"2009","journal-title":"Kidney Int"},{"key":"R24-9-20230601","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","article-title":"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R26-9-20230601","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phrs.2005.11.003","article-title":"Effect of N-acetylcysteine on neutrophil activation markers in healthy volunteers: In vivo and in vitro study","volume":"53","author":"Sadowska","year":"2006","journal-title":"Pharmacol Res"},{"key":"R27-9-20230601","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"R28-9-20230601","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"R29-9-20230601","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappa B in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"R30-9-20230601","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1525-139X.2002.00083.x","article-title":"Inflammation in end-stage renal disease: Sources, consequences, and therapy","volume":"15","author":"Stenvinkel","year":"2002","journal-title":"Semin Dial"},{"key":"R31-9-20230601","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000320765","article-title":"Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: An in vitro evaluation","volume":"30","author":"Schepers","year":"2010","journal-title":"Blood Purif"},{"key":"R32-9-20230601","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int"},{"key":"R33-9-20230601","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1681\/ASN.2007030355","article-title":"Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD","volume":"19","author":"Ramos","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R34-9-20230601","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10238-009-0035-3","article-title":"Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis","volume":"9","author":"Oner-Iyidogan","year":"2009","journal-title":"Clin Exp Med"},{"key":"R35-9-20230601","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ki.5001632","article-title":"ADMA, proteinuria and insulin resistance in non-diabetic stage I chronic kidney disease","volume":"70","author":"Caglar","year":"2006","journal-title":"Kidney Int"},{"key":"R36-9-20230601","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ndt\/gfl719","article-title":"Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections","volume":"22","author":"Zoccali","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R37-9-20230601","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","article-title":"Symmetric dimethylarginine (SDMA) as endogenous marker of renal function: A meta-analysis","volume":"21","author":"Kielstein","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R38-9-20230601","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000322614","article-title":"Symmetrical dimethylarginine outperforms CKD-EPI and MDRD-derived eGFR for the assessment of renal function in patients with adult congenital heart disease","volume":"34","author":"Tutarel","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"R39-9-20230601","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1054\/clnu.2002.0613","article-title":"Asymmetrical dimethylarginine (ADMA) in critically ill patients: High plasma ADMA concentration is an independent risk factor of ICU mortality","volume":"22","author":"Nijveldt","year":"2003","journal-title":"Clinical Nutrition"},{"key":"R40-9-20230601","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1525-1594.2007.00434.x","article-title":"Inconsistency of reported uremic toxin concentrations","volume":"31","author":"Meert","year":"2007","journal-title":"Artif Organs"},{"key":"R41-9-20230601","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1681\/ASN.V132490","article-title":"Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R42-9-20230601","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progresssion of chronic kidney disease: The mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R43-9-20230601","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.V891437","article-title":"Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients","volume":"8","author":"Anderstam","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R44-9-20230601","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0955-0674(93)90080-A","article-title":"Protein methylation","volume":"5","author":"Clarke","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"R45-9-20230601","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1177\/1358836X0501000111","article-title":"ADMA metabolism and clearance","volume":"10","author":"Teerlink","year":"2005","journal-title":"Vasc Med"},{"key":"R46-9-20230601","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.ftd.0000179849.42395.11","article-title":"The DDAH-ADMA-NOS pathway","volume":"27","author":"Leiper","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R47-9-20230601","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"Achan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R48-9-20230601","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5414\/CNP62295","article-title":"Low dialysance of asymmetric dimethylarginine (ADMA): In vivo and in vitro evidence of significant protein binding","volume":"62","author":"Kielstein","year":"2004","journal-title":"Clin Nephrol"},{"key":"R49-9-20230601","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000095360","article-title":"No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients","volume":"24","author":"Kalousova","year":"2006","journal-title":"Blood Purif"},{"key":"R50-9-20230601","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000104868","article-title":"Plasma dimethylarginine levels in chronic hemodialysis patients are independent of the type of dialyzer applied","volume":"25","author":"Grooteman","year":"2007","journal-title":"Blood Purif"},{"key":"R51-9-20230601","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1046\/j.1523-1755.2001.59780019.x","article-title":"Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes","volume":"78","author":"Schroder","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"R52-9-20230601","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1523-1755.2003.00044.x","article-title":"AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients","volume":"64","author":"Witko-Sarsat","year":"2003","journal-title":"Kidney Int"},{"key":"R53-9-20230601","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: A randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"R54-9-20230601","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine","volume":"343","author":"Tepel","year":"2000","journal-title":"N Engl J Med"},{"key":"R55-9-20230601","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00041552-200411000-00011","article-title":"N-Acetylcysteine in nephrology: Contrast nephropathy and beyond","volume":"13","author":"Tepel","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R56-9-20230601","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM200007203430311","article-title":"Acetylcysteine and nephrotoxic effects of radiographic contrast agents\u2013a new use for an old drug","volume":"343","author":"Safirstein","year":"2000","journal-title":"N Engl J Med"},{"key":"R57-9-20230601","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.ajkd.2006.11.026","article-title":"Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis","volume":"49","author":"Krane","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R58-9-20230601","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"key":"R59-9-20230601","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201110000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:41:09Z","timestamp":1786369269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201110000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.01720211","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}